GeneDx Holdings Corp. (WGS)
NASDAQ · Healthcare
GeneDx Holdings Corp. Gross Profit 2019–2025
GeneDx Holdings Corp. annual/quarterly gross profit history and growth rate from 2019 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- GeneDx Holdings Corp. gross profit for the quarter ending March 31, 2026 was 68.2 M, a 16.65% increase year-over-year.
- GeneDx Holdings Corp. gross profit for the twelve months ending March 31, 2026 was 282.1 M, a 83.85% increase year-over-year.
- GeneDx Holdings Corp. annual gross profit for 2025 was 298.2 M, a 53.38% increase from 2024.
- GeneDx Holdings Corp. annual gross profit for 2024 was 194.4 M, a 115.98% increase from 2023.
- GeneDx Holdings Corp. annual gross profit for 2023 was 90.0 M, a 436.47% decrease from 2022.
- GeneDx Holdings Corp. annual gross profit for 2022 was -26.8 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
GeneDx Holdings Corp. Gross Profit — FAQ
GeneDx Holdings Corp. (WGS) gross profit over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is GeneDx Holdings Corp.'s gross profit?
GeneDx Holdings Corp. (WGS) reported gross profit of $298M for fiscal 2025.
Where can I see WGS's gross profit history?
The chart and table above show GeneDx Holdings Corp.'s gross profit by year and by quarter, including the growth rate.